This expert article focusses on the new proportionate approach, and the international recognition pr...
Read moreWe've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a...
Read moreThe Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreJ&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde...
Read moreWe explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreOur client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...
Read more